Release Date: 14/07/10 13:00 Summary: Appendix 3Y Change of Directors Interest - Baynton Price Sensitive: No Download Document 109.88KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%